Diagnosis and management of increased intracranial pressure

L J Dennis1, S A Mayer

  • 1Neurological Intensive Care Unit, Columbia-Presbyterian Medical Center, New York, NY, USA.

Neurology India
|March 13, 2002
PubMed

Insights

Managing increased intracranial pressure (ICP) involves reducing skull volume. Stepwise treatment protocols, including ICP monitoring and CPP control, are crucial for preventing brain damage in neurological diseases.

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Increased intracranial pressure (ICP) is a critical condition in various neurological diseases, stemming from added volume within the skull.
  • Elevated ICP can cause severe brain damage or death through reduced cerebral perfusion pressure (CPP) and mechanical distortion.
  • Effective ICP management aims to decrease intracranial volume and preserve brain function.

Purpose of the Study:

  • To outline the principles and stepwise management strategies for elevated intracranial pressure (ICP).
  • To highlight the importance of ICP monitoring and control of cerebral perfusion pressure (CPP) in neurological patients.

Main Methods:

  • Accurate ICP measurement using fluid-coupled ventricular catheters or fiberoptic transducers.
  • A stepwise treatment protocol for critically elevated ICP, including neuroimaging, sedation, CPP manipulation, mannitol, hyperventilation, and potentially pentobarbital therapy.
  • Consideration of moderate hypothermia as an emerging treatment for refractory ICP.

Main Results:

  • Rapid ICP reduction in unmonitored patients can be achieved with head elevation, hyperventilation, and mannitol.
  • A structured, stepwise approach is essential for managing monitored patients with critically high ICP.
  • ICP monitoring is identified as the critical first step in managing elevated ICP.

Conclusions:

  • Stepwise management protocols, prioritizing ICP monitoring, sedation, and CPP control, are vital for treating increased intracranial pressure.
  • Timely and appropriate interventions can mitigate the risks of brain damage associated with elevated ICP.
  • Emerging therapies like moderate hypothermia show potential for managing refractory ICP cases.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...